Changes in Splicing Machinery Components Influence, Precede, and Early Predict the Development of Type 2 Diabetes:

Manuel D Gahete1, Mercedes Del Rio-Moreno1, Antonio Camargo2

  • 1Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain.; Universidad de Córdoba, Córdoba, Spain.; Reina Sofia University Hospital, Córdoba, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Córdoba, Spain.

Ebiomedicine
|November 18, 2018
PubMed
Abstract

Insights

Alterations in splicing machinery components precede and predict Type-2 diabetes mellitus (T2DM) development in cardiovascular disease patients. These changes in gene expression offer a new risk assessment tool for T2DM.

Area of Science:

  • Molecular biology
  • Genetics
  • Endocrinology

Background:

  • Type-2 diabetes mellitus (T2DM) is a growing global health concern, significantly increasing cardiovascular disease risk.
  • Aberrant gene expression and splicing are linked to T2DM, suggesting a role for splicing machinery dysregulation.

Purpose of the Study:

  • To investigate if splicing machinery dysregulations precede, contribute to, and predict T2DM development.
  • To analyze splicing machinery component expression in patients with cardiovascular disease.

Main Methods:

  • Studied 215 patients with cardiovascular disease, assessing splicing machinery component expression in peripheral blood mononuclear cells (PBMCs).
  • Compared baseline fasting and postprandial PBMCs from patients who developed T2DM (n=107) versus those who did not (n=108) over 5 years.
  • In vitro analysis of PBMC splicing machinery expression using serum from T2DM patients.

Main Results:

  • Markedly altered expression of key splicing machinery components (e.g., RNU2, RNU4, RNU12) in incident T2DM patients' PBMCs.
  • Serum from incident T2DM patients reduced splicing machinery component expression in healthy PBMCs.
  • Fasting/postprandial splicing machinery component levels in PBMCs predicted T2DM risk (OR > 4) and development (AUC > 0.85).

Conclusions:

  • Splicing machinery alterations are present before and can predict T2DM development in cardiovascular disease patients.
  • These findings highlight splicing machinery as a potential biomarker for T2DM risk assessment.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.2K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.1K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.6K
Predicting Products: SN1 vs. SN202:27

Predicting Products: SN1 vs. SN2

Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
17.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K